These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18655073)

  • 21. Solvation-assisted pressure tuning of insulin fibrillation: from novel aggregation pathways to biotechnological applications.
    Grudzielanek S; Smirnovas V; Winter R
    J Mol Biol; 2006 Feb; 356(2):497-509. PubMed ID: 16376376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Energy barriers for HET-s prion forming domain amyloid formation.
    Sabaté R; Castillo V; Espargaró A; Saupe SJ; Ventura S
    FEBS J; 2009 Sep; 276(18):5053-64. PubMed ID: 19682303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin amyloid fibrils form an inclusion complex with molecular iodine: a misfolded protein as a nanoscale scaffold.
    Dzwolak W
    Biochemistry; 2007 Feb; 46(6):1568-72. PubMed ID: 17279621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils.
    Vestergaard B; Groenning M; Roessle M; Kastrup JS; van de Weert M; Flink JM; Frokjaer S; Gajhede M; Svergun DI
    PLoS Biol; 2007 May; 5(5):e134. PubMed ID: 17472440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring and inhibition of insulin fibrillation by a small organic fluorogen with aggregation-induced emission characteristics.
    Hong Y; Meng L; Chen S; Leung CW; Da LT; Faisal M; Silva DA; Liu J; Lam JW; Huang X; Tang BZ
    J Am Chem Soc; 2012 Jan; 134(3):1680-9. PubMed ID: 22191699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid fibrillation of human Apaf-1 CARD.
    Rao PN; Reddy KS; Bhuyan AK
    Biochemistry; 2009 Aug; 48(32):7656-64. PubMed ID: 19603830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary nucleation and accessible surface in insulin amyloid fibril formation.
    Foderà V; Librizzi F; Groenning M; van de Weert M; Leone M
    J Phys Chem B; 2008 Mar; 112(12):3853-8. PubMed ID: 18311965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noncooperative dimethyl sulfoxide-induced dissection of insulin fibrils: toward soluble building blocks of amyloid.
    Loksztejn A; Dzwolak W
    Biochemistry; 2009 Jun; 48(22):4846-51. PubMed ID: 19385641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing the mechanism of insulin aggregation with added metalloporphyrins.
    Sibley SP; Sosinsky K; Gulian LE; Gibbs EJ; Pasternack RF
    Biochemistry; 2008 Mar; 47(9):2858-65. PubMed ID: 18220359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing the nucleus model for oligomer formation during insulin amyloid fibrillogenesis.
    Pease LF; Sorci M; Guha S; Tsai DH; Zachariah MR; Tarlov MJ; Belfort G
    Biophys J; 2010 Dec; 99(12):3979-85. PubMed ID: 21156140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregation mechanism investigation of the GIFQINS cross-beta amyloid fibril.
    Chen HF
    Comput Biol Chem; 2009 Feb; 33(1):41-5. PubMed ID: 18755632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural characterization of prefibrillar intermediates and amyloid fibrils by small-angle X-ray scattering.
    Langkilde AE; Vestergaard B
    Methods Mol Biol; 2012; 849():137-55. PubMed ID: 22528088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stabilization of a native protein mediated by ligand binding inhibits amyloid formation independently of the aggregation pathway.
    Soldi G; Plakoutsi G; Taddei N; Chiti F
    J Med Chem; 2006 Oct; 49(20):6057-64. PubMed ID: 17004719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic analysis provides insight into the mechanism of ribonuclease A oligomer formation.
    López-Alonso JP; Gotte G; Laurents DV
    Arch Biochem Biophys; 2009 Sep; 489(1-2):41-7. PubMed ID: 19638275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermal dependence of thermally induced protein spherulite formation and growth: kinetics of beta-lactoglobulin and insulin.
    Domike KR; Donald AM
    Biomacromolecules; 2007 Dec; 8(12):3930-7. PubMed ID: 18039002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils.
    Arimon M; Grimminger V; Sanz F; Lashuel HA
    J Mol Biol; 2008 Dec; 384(5):1157-73. PubMed ID: 18851977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods for structural characterization of prefibrillar intermediates and amyloid fibrils.
    Langkilde AE; Vestergaard B
    FEBS Lett; 2009 Aug; 583(16):2600-9. PubMed ID: 19481541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photocontrol of beta-amyloid peptide (1-40) fibril growth in the presence of a photosurfactant.
    Hamill AC; Lee CT
    J Phys Chem B; 2009 Apr; 113(17):6164-72. PubMed ID: 19344185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solvent effects on the dynamics of amyloidogenic insulin revealed by neutron spin echo spectroscopy.
    Erlkamp M; Grobelny S; Faraone A; Czeslik C; Winter R
    J Phys Chem B; 2014 Mar; 118(12):3310-6. PubMed ID: 24611749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired processing of human pro-islet amyloid polypeptide is not a causative factor for fibril formation or membrane damage in vitro.
    Khemtémourian L; Lahoz Casarramona G; Suylen DP; Hackeng TM; Meeldijk JD; de Kruijff B; Höppener JW; Killian JA
    Biochemistry; 2009 Nov; 48(46):10918-25. PubMed ID: 19817482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.